AKT1 and cancer: Pearson et al.52 demonstrated that combining honokiol with cetuximab produced significant antiproliferative effects in cetuximab-resistant cancer cells.53 The combination downregulated the human epidermal growth factor receptor (HER) family members and inhibited associated signaling pathways, including MAPK and AKT.